Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes
Abstract Background Atherosclerotic cardiovascular diseases (CVD) is the leading cause of death in diabetes, but the full range of biomarkers reflecting atherosclerotic burden and CVD risk in people with diabetes is unknown. Metabolomics may help identify novel biomarkers potentially involved in dev...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2022-04-01
|
| Серія: | Cardiovascular Diabetology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12933-022-01493-w |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|